BRPI0712273A2 - Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit - Google Patents
Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit Download PDFInfo
- Publication number
- BRPI0712273A2 BRPI0712273A2 BRPI0712273-0A BRPI0712273A BRPI0712273A2 BR PI0712273 A2 BRPI0712273 A2 BR PI0712273A2 BR PI0712273 A BRPI0712273 A BR PI0712273A BR PI0712273 A2 BRPI0712273 A2 BR PI0712273A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibody
- methods
- diagnose
- kit
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pregnancy & Childbirth (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
ANTICORPOS ISOLADOS, POLIPEPTÍDEOS IMUNOGLOBULINAS, ANTICORPO HEPSINA, MOLÉCULA DE ÁCIDO NUCLEICO, CÉLULA HOSPEDEIRA, LINHAGEM CELULAR, MÉTODOS PARA PRODUZIR O ANTICORPO, PARA DIAGNOSTICAR A PRESENÇA DE HEPSINA, TRATAR UMA DOENÇA, PARA MONITORAR A DOENÇA RESIDUAL, PARA DETECTAR O ESTADO DA DOENÇA, PARA DIAGNOSTICAR UMA DISFUNÇçO, COMPOSIÇçO, ARRANJO OU CHIP DE PROTEÍNA E KIT <UM>RESUMO<MV> São fornecidos anticorpos monoclonais anti-HEPSINA e métodos para uso dos mesmos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80558906P | 2006-06-22 | 2006-06-22 | |
US60/805,589 | 2006-06-22 | ||
PCT/US2007/071688 WO2007149932A2 (en) | 2006-06-22 | 2007-06-20 | Methods and compositions for targeting hepsin |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0712273A2 true BRPI0712273A2 (pt) | 2012-03-06 |
BRPI0712273A8 BRPI0712273A8 (pt) | 2019-01-22 |
Family
ID=38754528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0712273A BRPI0712273A8 (pt) | 2006-06-22 | 2007-06-20 | anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit |
Country Status (16)
Country | Link |
---|---|
US (2) | US8124352B2 (pt) |
EP (1) | EP2044124A2 (pt) |
JP (1) | JP2009540835A (pt) |
KR (1) | KR101410195B1 (pt) |
CN (1) | CN101490088B (pt) |
AU (1) | AU2007260950B2 (pt) |
BR (1) | BRPI0712273A8 (pt) |
CA (1) | CA2656168A1 (pt) |
IL (1) | IL195561A (pt) |
MX (1) | MX2008015882A (pt) |
MY (1) | MY150643A (pt) |
NO (1) | NO20090333L (pt) |
NZ (1) | NZ573178A (pt) |
RU (1) | RU2009101813A (pt) |
WO (1) | WO2007149932A2 (pt) |
ZA (1) | ZA200810225B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7947436B2 (en) | 2004-12-13 | 2011-05-24 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
MX2008015882A (es) | 2006-06-22 | 2009-01-12 | Genentech Inc | Metodos y composiciones para hacer blanco en hepsina. |
EP2491059B1 (en) * | 2009-10-22 | 2015-02-25 | F.Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods using same |
BR112012009409A2 (pt) * | 2009-10-22 | 2017-02-21 | Genentech Inc | método de identificação de uma substância inibidora, molécula antagonista, ácido nucleico isolado, vetor, célula hospedeira, método para fabricar a molécula, composição, artigo de fabricação, método de inibição de uma atividade biológica, método de tratamento de uma condição patológica, método para detectar msp em uma amostra e método para detectar hepsina em uma amostra |
JP5797210B2 (ja) * | 2010-03-02 | 2015-10-21 | シアトル ジェネティックス, インコーポレイテッド | 抗体をスクリーニングするための方法 |
WO2011161189A1 (en) | 2010-06-24 | 2011-12-29 | F. Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods of use |
DK3415531T3 (da) * | 2011-05-27 | 2023-09-18 | Glaxo Group Ltd | Bcma (cd269/tnfrsf17)-bindende proteiner |
UA112434C2 (uk) | 2011-05-27 | 2016-09-12 | Ґлаксо Ґруп Лімітед | Антигензв'язувальний білок, який специфічно зв'язується з всма |
WO2017162659A1 (en) | 2016-03-24 | 2017-09-28 | Bayer Pharma Aktiengesellschaft | Intracellular hepsin as therapeutic target for the treatment of cancer with centrosome amplification |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6268165B1 (en) | 1997-03-19 | 2001-07-31 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian cancer |
US7282198B2 (en) | 1997-03-19 | 2007-10-16 | The University Of Arkansas For Medical Sciences | Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
US5981830A (en) * | 1997-05-30 | 1999-11-09 | Schering Aktiengesellschaft | Knockout mice and their progeny with a disrupted hepsin gene |
ATE496123T1 (de) | 2000-02-03 | 2011-02-15 | Dendreon Corp | Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden |
US6423543B1 (en) * | 2000-12-20 | 2002-07-23 | Isis Pharmaceuticals, Inc. | Antisense modulation of hepsin expression |
US20030013097A1 (en) * | 2001-01-23 | 2003-01-16 | Welsh John Barnard | Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
AU2002240336A1 (en) * | 2001-02-14 | 2002-08-28 | Tularik Inc. | Methods for the diagnosis and treatment of tumors employing the hepsin gene |
US6482630B2 (en) * | 2001-03-29 | 2002-11-19 | Applera Corporation | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
US7229774B2 (en) * | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
WO2003016484A2 (en) | 2001-08-17 | 2003-02-27 | Affymetrix, Inc. | Gleason grade 4/5 prostate cancer genes |
AU2003225540A1 (en) * | 2002-01-31 | 2003-09-02 | Irm, Llc | Hepsin substrates and prodrugs |
US20040001801A1 (en) * | 2002-05-23 | 2004-01-01 | Corvas International, Inc. | Conjugates activated by cell surface proteases and therapeutic uses thereof |
JP3775346B2 (ja) * | 2002-05-29 | 2006-05-17 | 株式会社日立製作所 | テレビ電話システムおよびその端末装置 |
WO2004009803A2 (en) | 2002-07-23 | 2004-01-29 | Bayer Healthcare Ag | Regulation of human hepsin |
US6977170B2 (en) | 2002-09-06 | 2005-12-20 | Applera Corporation | Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof |
EP1558731A4 (en) * | 2002-10-04 | 2007-01-10 | Schering Ag | MODIFIED HEPSINE MOLECULES COMPRISING A SUBSTITUTION ACTIVATION SEQUENCE AND USES THEREOF |
JP5226308B2 (ja) | 2004-07-26 | 2013-07-03 | ジェネンテック, インコーポレイテッド | 肝細胞増殖因子活性化を制御するための方法及び組成物 |
MX2008015882A (es) | 2006-06-22 | 2009-01-12 | Genentech Inc | Metodos y composiciones para hacer blanco en hepsina. |
NZ596729A (en) | 2006-06-22 | 2012-11-30 | Genentech Inc | Methods for identifying a candidate inhibitor substance that inhibits hepsin activation of pro-urokinase type plasminogen activator |
EP2491059B1 (en) * | 2009-10-22 | 2015-02-25 | F.Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods using same |
-
2007
- 2007-06-20 MX MX2008015882A patent/MX2008015882A/es active IP Right Grant
- 2007-06-20 WO PCT/US2007/071688 patent/WO2007149932A2/en active Application Filing
- 2007-06-20 EP EP07798834A patent/EP2044124A2/en not_active Withdrawn
- 2007-06-20 NZ NZ573178A patent/NZ573178A/en not_active IP Right Cessation
- 2007-06-20 AU AU2007260950A patent/AU2007260950B2/en not_active Ceased
- 2007-06-20 CA CA002656168A patent/CA2656168A1/en not_active Abandoned
- 2007-06-20 BR BRPI0712273A patent/BRPI0712273A8/pt not_active Application Discontinuation
- 2007-06-20 JP JP2009516706A patent/JP2009540835A/ja active Pending
- 2007-06-20 RU RU2009101813/10A patent/RU2009101813A/ru not_active Application Discontinuation
- 2007-06-20 KR KR1020097001309A patent/KR101410195B1/ko not_active IP Right Cessation
- 2007-06-20 ZA ZA200810225A patent/ZA200810225B/xx unknown
- 2007-06-20 US US12/306,208 patent/US8124352B2/en not_active Expired - Fee Related
- 2007-06-20 MY MYPI20085215 patent/MY150643A/en unknown
- 2007-06-20 CN CN200780027496.XA patent/CN101490088B/zh not_active Expired - Fee Related
-
2008
- 2008-11-27 IL IL195561A patent/IL195561A/en active IP Right Grant
-
2009
- 2009-01-21 NO NO20090333A patent/NO20090333L/no not_active Application Discontinuation
-
2012
- 2012-01-20 US US13/355,243 patent/US8383123B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20100021474A1 (en) | 2010-01-28 |
US8383123B2 (en) | 2013-02-26 |
NO20090333L (no) | 2009-03-23 |
IL195561A0 (en) | 2011-08-01 |
WO2007149932A2 (en) | 2007-12-27 |
AU2007260950A8 (en) | 2009-01-22 |
ZA200810225B (en) | 2010-03-31 |
AU2007260950A1 (en) | 2007-12-27 |
US20120141374A1 (en) | 2012-06-07 |
EP2044124A2 (en) | 2009-04-08 |
WO2007149932A3 (en) | 2008-05-02 |
MX2008015882A (es) | 2009-01-12 |
MY150643A (en) | 2014-02-14 |
BRPI0712273A8 (pt) | 2019-01-22 |
CN101490088B (zh) | 2015-04-08 |
JP2009540835A (ja) | 2009-11-26 |
KR20090029276A (ko) | 2009-03-20 |
AU2007260950B2 (en) | 2011-09-15 |
CA2656168A1 (en) | 2007-12-27 |
IL195561A (en) | 2013-04-30 |
KR101410195B1 (ko) | 2014-06-19 |
US8124352B2 (en) | 2012-02-28 |
RU2009101813A (ru) | 2010-07-27 |
CN101490088A (zh) | 2009-07-22 |
NZ573178A (en) | 2012-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0712273A2 (pt) | Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit | |
BR112014010161A2 (pt) | anticorpo monoclonal antiproteína de ligação ao dna tar de 43 kda (tdp-43) e seus método de preparação e uso no tratamento de proteinopatia tdp-43, bem como composições, polinucleotídeo, método in vitro e kit para diagnosticar proteinopatia tdp-43 | |
PH12016500658A1 (en) | Human anti-alpha-synuclein autoantibodies | |
CY1118880T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
BRPI0519775A2 (pt) | proteÍna isolada de ligaÇço a antÍgeno, polinucleotÍdeo isolado, plasmÍdio e cÉlula isolada e composiÇço farmacÊutica | |
AR067199A1 (es) | Proteinas de union a antigenos que se unen a par-2 | |
EA200801621A1 (ru) | Антитела, направленные на her-3, и их применение | |
CO6710903A2 (es) | Un anticuerpo que reconoce y se une específicamente con un fosfo-epítope en la proteína tau de mamífero o en uno de sus fragmentos y una composición comprendiendo el mismo | |
BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
EA201100231A1 (ru) | Диагностический анализ на основе антител | |
ATE443161T1 (de) | Mittel und verfahren für den nachweis von methylierter dna | |
ATE283289T1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
JP2013116897A5 (pt) | ||
WO2008136848A3 (en) | Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease | |
EP2332988A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
KR102311590B1 (ko) | 신장 질환 및 치주 질환의 검출 및 진단을 위한 방법 및 조성물 | |
ATE474857T1 (de) | Antikörper gegen ein epitop auf agr2, assays und hybridome | |
WO2007111875A3 (en) | Methods for diagnosing and treating kidney and colorectal cancer | |
BR112013021056A2 (pt) | anticorpo monoclonal, linhagem de células de hibridoma, kit para diagnóstico, métodos para a produção de um anticorpo monoclonal e de um agente de ligação, agente de ligação sequência de aminoácidos purificada, método para a obtenção de uma sequência do ácido nucleico codificante, molécula do ácido nucleico isolado codificante, vetor, célula hospedeira isolada, proteína de fusão, método de triagem para a presença de uma doença, de uma condição, métodos de diagnóstico de um indivíduo, de prognóstico para um indivíduo, e de monitoramento de um indivúdo, e, método para detecção da presença ou ausência de um câncer cervical | |
EP2083018A3 (en) | Compositions and methods relating to STOP-1 | |
UA98632C2 (ru) | Антагонистические антитела к notch3 и их применение для профилактики и лечения связанных с notch3 заболеваний | |
DE502004008729D1 (de) | Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung | |
RU2011109883A (ru) | Способ диагностики рака мочевого пузыря с помощью онкомаркера kifc1 (варианты) и набор для его осуществления | |
AU2016100899A4 (en) | Method of determining the presence and/or amount of osteopontin, a kit and their use for diagnosis and prognosis | |
MX360580B (es) | Autoanticuerpos humanos anti-alfa-sinucleina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |